Experimental Medicine for HIV Vaccine Research and Development.

Prudden, Holly; Tatoud, Roger; Slack, Cathy; Shattock, Robin; Anklesaria, Pervin; Bekker, Linda-Gail; Buchbinder, Susan

Prudden, Holly; Tatoud, Roger; Slack, Cathy; Shattock, Robin; Anklesaria, Pervin; Bekker, Linda-Gail; Buchbinder, Susan.

Afiliación

Prudden H; Independent Consultant, London TN7 4AS, UK.
Tatoud R; Origena Consulting, 01210 Ferney Voltaire, France.
Slack C; HIV/AIDS Vaccines Ethics Group (HAVEG), University of KwaZulu-Natal, Durban 4041, South Africa.
Shattock R; Imperial College London, London SW7 2BX, UK.
Anklesaria P; Bill & Melinda Gates Foundation, Seattle, WA 98109, USA.
Bekker LG; The Desmond Tutu HIV Centre, Faculty of Health Sciences, University of Cape Town, Cape Town 7925, South Africa.
Buchbinder S; Bridge HIV, San Francisco Department of Public Health, San Francisco, CA 94102, USA.

Vaccines (Basel) ; 11(5)2023 May 11.

Article en En | MEDLINE | ID: mdl-37243074

Palabras clave

HIV prevention; HIV vaccine; clinical trial; experimental medicine; research methods

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Aspecto: Ethics Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google